Successive Intramuscular Boosting with IFN-Alpha Protects Mycobacterium bovis BCG-Vaccinated Mice against M. lepraemurium Infection

scientific article published on 21 September 2015

Successive Intramuscular Boosting with IFN-Alpha Protects Mycobacterium bovis BCG-Vaccinated Mice against M. lepraemurium Infection is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2015/414027
P932PMC publication ID4592887
P698PubMed publication ID26484351
P5875ResearchGate publication ID283757099

P50authorJavier Rangel-MorenoQ37372961
P2093author name stringG G Guerrero
Ó Rojas-Espinosa
S Islas-Trujillo
P2860cites workMolecular characterization of the mycobacterial heparin-binding hemagglutinin, a mycobacterial adhesinQ28486660
Nitric oxide and macrophage functionQ29615327
Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophagesQ29617356
TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection.Q30375496
Expression of Toll-like receptor 2 on human Schwann cells: a mechanism of nerve damage in leprosyQ30531768
How does Mycobacterium leprae target the peripheral nervous system?Q33818891
Natural adjuvants: endogenous activators of dendritic cellsQ33878894
Leprosy lipid provides the key to Schwann cell entryQ34137960
Leprosy bacillus--possibly the first chemoautotrophic human pathogen cultivated in vitro and characterisedQ34554703
IFNs and STATs in innate immunity to microorganismsQ34647015
Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogensQ34657537
Dendritic cells and immunity to Listeria: TipDCs are a new recruitQ35810870
Adjuvant activity of interferon alpha: mechanism(s) of action.Q50724369
IFNs and STATs in innate immunity to microorganismsQ57174196
M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid CellsQ59498046
Type I interferons produced by dendritic cells promote their phenotypic and functional activationQ61473768
Binding of 14C-labeled dopa by Mycobacterium leprae in vitroQ67522633
Parameters of interferon action: II. Immunological effects of recombinant leukocyte interferon (IFN-alpha 2) in phase I-II trialsQ71001088
Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine modelQ74334942
The effect of exogenous peroxidase on the evolution of murine leprosyQ78668200
Expression of cyclooxygenase-2, alpha 1-acid-glycoprotein and inducible nitric oxide synthase in the developing lesions of murine leprosyQ79556035
New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosyQ35936136
Type I interferons (alpha/beta) in immunity and autoimmunityQ36072422
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalkQ36733068
The role of type I interferon production by dendritic cells in host defenseQ36838232
Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responsesQ36842908
Type I interferon as a stimulus for cross-primingQ37027815
Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria.Q37355847
The innate immune response in leprosyQ37671102
New pathways of protective and pathological host defense to mycobacteriaQ38025523
Insights from animal models on the immunogenetics of leprosy: a reviewQ38071240
Biomarkers for leprosy: would you prefer T (cells)?Q38112443
Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infectionQ41990768
Type I interferons regulate cytolytic activity of memory CD8(+) T cells in the lung airways during respiratory virus challengeQ42712613
Integrated pathways for neutrophil recruitment and inflammation in leprosyQ42930976
Leprosy: what is being "eliminated"?Q43187062
Expression of inducible nitric oxide synthase and nitrotyrosine during the evolution of experimental pulmonary tuberculosisQ43772784
Recognition of lipid antigens by sera of mice infected with Mycobacterium lepraemuriumQ44563252
Nitrotyrosine localization to dermal nerves in borderline leprosy.Q44804918
IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells.Q45871212
Palsy of the rear limbs in Mycobacterium lepraemurium-infected mice results from bone damage and not from nerve involvementQ46524702
Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen speciesQ47774945
P275copyright licenseCreative Commons Attribution 3.0 UnportedQ14947546
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectMycobacterium bovisQ133447
P304page(s)414027
P577publication date2015-09-21
P1433published inBioMed Research InternationalQ17509958
P1476titleSuccessive Intramuscular Boosting with IFN-Alpha Protects Mycobacterium bovis BCG-Vaccinated Mice against M. lepraemurium Infection
P478volume2015

Reverse relations

cites work (P2860)
Q47099186IFN-α Boosting of Mycobacterium bovis Bacillus Calmette Güerin-Vaccine Promoted Th1 Type Cellular Response and Protection against M. tuberculosis Infection
Q52657152Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application.

Search more.